Citicoline sodium

This classification denotes the sodium form of a nootropic agent with the molecular formula C14H25N4O11P2.H+, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 536BQ2JVC7, chemically known as cytidine 5-(trihydrogen pyrophosphate), monoester with choline hydroxide, inner salt but more generally known as citicoline, which bears US NIH Compound Identifier 291. European Medicines Agency schedules Citicoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07489MIG. World Health Organization schedules citicoline in its Anatomical Therapeutic Chemical (ATC) Classification. CITICOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule citicoline sodium under HS 29349990 and SITC 51579. As of Q4 2014, CITICOLINE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: C[N+](C)(C)CCOP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2CCC(NC2=O)N)O)O.[NA+].